Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
Bones News
Friday, March 12, 2010 Long-term Bisphosphonate Use May Actually Increase Fracture Risk
The osteoporosis drugs may boost bone quantity at the expense of bone quality, eventually weakening users' bones...
Thursday, November 05, 2009 TNFα Weakens Bones in Diabetes
High levels of TNF-α in diabetics accelerates cartilage loss, weakens bones, and slows fracture healing...
Friday, September 11, 2009 Splits Form Over How to Address Bone Loss
Osteopenia—bone density that is below what is considered normal but not low enough to be considered osteoporosis—can be a confusing diagnosis, and experts are split over whether patients should begin taking drugs to inhibit bone loss when only in the osteopenia stage
Thursday, August 27, 2009 Study: Hip Fracture Rates On the Decline in Canada
Hip fracture rates in Canada have been declining since 1985, with a more rapid drop between 1996 and 2005...
Thursday, August 20, 2009 Mimicking Human Cartilage to Repair a Knee
Companies are developing off-the-shelf plugs that are engineered to mimic the composition of human bone and cartilage to use instead of transplanted cartilage when repairing injured knees...
Monday, August 10, 2009 Millions of Children In US Found to Be Lacking Vitamin D
Millions of young Americans have disturbingly low vitamin D levels, which may increase their risk for bone problems, heart disease, and diabetes later in life...
Thursday, July 30, 2009 GSK Buys $120 Million Piece of Denosumab
GlaxoSmithKline will share denosumab osteoporosis sales in Europe and emerging markets...
Thursday, July 16, 2009 Hand BMD Predicts RA Mortality
Hand bone mineral density measured by digital X-ray radiogrammetry may help doctors better predict risk of joint damage and mortality among individuals with RA...
Thursday, July 09, 2009 Amgen's Denosumab Bests Zometa in Breast Cancer Patients
The first of three pivotal oncology trials comparing denosumab to Zometa in the advanced cancer setting meets primary and secondary endpoints...
Tuesday, June 30, 2009 Assessment of Bone Growth Stimulator Is Mixed
Bone-morphogenic protein (BMP) is being increasingly used in the US to stimulate the creation of new bone during spinal fusion surgery, despite higher costs and complication rates...